Brief: Unity Biotechnology Q2 Operating Income USD -6.979 Million
06/08/2024 21:30
Aug 06 (Reuters) - Unity Biotechnology Q2 basic EPS USD -0.31. * Q2 operating expenses USD 6.979 million * Q2 net income USD -5.279 million
Recent news on Unity Biotechnology
See all newsU.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution
Brief: Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
Brief: UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force